KDOQI: Definition and Classification of Stages of Chronic Kidney Disease. 2002, [http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g2.htm]
Google Scholar
Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2004, 13 (1): 73-81.
Article
PubMed
Google Scholar
Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007, 116 (1): 85-97.
Article
PubMed
Google Scholar
Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006, 145 (4): 237-46.
Article
CAS
PubMed
Google Scholar
Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005, 352 (20): 2049-60.
Article
CAS
PubMed
Google Scholar
Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, et al: Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2006, 17 (1): 254-61.
Article
CAS
PubMed
Google Scholar
Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. Clin J Am Soc Nephrol. 2008, 3 (2): 505-21.
Article
CAS
PubMed
Google Scholar
Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000, 58 (1): 353-62.
Article
CAS
PubMed
Google Scholar
Massy ZA, Taupin P, Jungers P, Landais P: Prediction model of coronary heart disease in patients with chronic kidney disease: role of plasma fibrinogen as a new prognostic variable. Prilozi. 2005, 26 (2): 63-77.
PubMed
Google Scholar
Spiegel DM, Raggi P, Smits G, Block GA: Factors associated with mortality in patients new to haemodialysis. Nephrol Dial Transplant. 2007, 22 (12): 3568-72.
Article
CAS
PubMed
Google Scholar
Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW: Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol. 2009, 6 (7): 464-74.
Article
CAS
PubMed
Google Scholar
Shlipak MG, Fried LF, Stehman-Breen C, Siscovick D, Newman AB: Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study. Am J Geriatr Cardiol. 2004, 13 (2): 81-90.
Article
PubMed
Google Scholar
Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, et al: Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005, 118 (12): 1416-
Article
PubMed
Google Scholar
Keller C, Katz R, Sarnak MJ, Fried LF, Kestenbaum B, Cushman M, et al: Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant. 2010, 25 (1): 119-24.
Article
CAS
PubMed
Google Scholar
Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, et al: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007, 71 (3): 239-44.
Article
CAS
PubMed
Google Scholar
Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG: Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant. 2007, 22 (4): 1087-92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al: Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002, 156 (9): 871-81.
Article
PubMed
Google Scholar
Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008, 51 (3): 395-406.
Article
CAS
PubMed
PubMed Central
Google Scholar
Murthy K, Stevens LA, Stark PC, Levey AS: Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. Kidney Int. 2005, 68 (4): 1884-7.
Article
CAS
PubMed
Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-12.
Article
PubMed
PubMed Central
Google Scholar
Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D: Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988, 71 (1): 220-5.
CAS
PubMed
Google Scholar
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-72.
Article
CAS
PubMed
Google Scholar
Nakano M, Furutani M, Shinno H, Ikeda T, Oida K, Ishii H: Elevation of soluble thrombomodulin antigen levels in the serum and urine of streptozotocin-induced diabetes model rats. Thromb Res. 2000, 99 (1): 83-91.
Article
CAS
PubMed
Google Scholar
Jacobson SH, Egberg N, Hylander B, Lundahl J: Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol. 2002, 22 (1): 42-7.
Article
PubMed
Google Scholar
Mezzano D, Tagle R, Pais E, Panes O, Perez M, Downey P, et al: Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure. Thromb Res. 1997, 88 (6): 465-72.
Article
CAS
PubMed
Google Scholar
Wu KK: Soluble thrombomodulin and coronary heart disease. Curr Opin Lipidol. 2003, 14 (4): 373-5.
Article
CAS
PubMed
Google Scholar
Breitenstein A, Tanner FC, Luscher TF: Tissue factor and cardiovascular disease. Circ J. 2010, 74 (1): 3-12.
Article
CAS
PubMed
Google Scholar
Toschi V: Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease. J Thromb Haemost. 2007, 5 (3): 472-4.
Article
CAS
PubMed
Google Scholar
Adams MJ, Irish AB, Watts GF, Oostryck R, Dogra GK: Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function. Thromb Res. 2008, 123 (2): 374-80.
Article
CAS
PubMed
Google Scholar
Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel R, et al: Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost. 2007, 5 (3): 475-82.
Article
CAS
PubMed
Google Scholar
Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK: Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol. 2001, 21 (4): 611-7.
Article
CAS
PubMed
Google Scholar
Wannamethee SG, Shaper AG, Lowe GD, Lennon L, Rumley A, Whincup PH: Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. Eur Heart J. 2006, 27 (24): 2975-81.
Article
CAS
PubMed
Google Scholar
Mannucci PM: von Willebrand factor: a marker of endothelial damage?. Arterioscler Thromb Vasc Biol. 1998, 18 (9): 1359-62.
Article
CAS
PubMed
Google Scholar
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004, 350 (14): 1387-97.
Article
CAS
PubMed
Google Scholar
Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP: Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol. 1999, 105 (1): 110-6.
Article
CAS
PubMed
Google Scholar
Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC: Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009, 53 (4): 596-605.
Article
PubMed
Google Scholar
Folsom AR, Delaney JA, Lutsey PL, Zakai NA, Jenny NS, Polak JF, et al: Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol. 2009, 84 (6): 349-53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, et al: Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol. 2006, 26 (12): 2793-9.
Article
CAS
PubMed
Google Scholar
Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR, et al: Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999, 19 (3): 493-8.
Article
CAS
PubMed
Google Scholar
Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, et al: D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2006, 4 (6): 1208-14.
Article
CAS
PubMed
Google Scholar
Wattanakit K, Cushman M: Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms. Curr Opin Pulm Med. 2009, 15 (5): 408-12.
Article
PubMed
PubMed Central
Google Scholar
Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M: Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant. 2010
Google Scholar
Ishii H, Nakano M, Tsubouchi J, Ishikawa T, Uchiyama H, Hiraishi S, et al: Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemost. 1990, 63 (2): 157-62.
CAS
PubMed
Google Scholar
Lwaleed BA, Chisholm M, Francis JL: Development and validation of an assay for urinary tissue factor activity. J Clin Pathol. 1999, 52 (3): 219-24.
Article
CAS
PubMed
PubMed Central
Google Scholar